Acrivon Therapeutics, Inc. · NASDAQ:ACRV

Masson Kristina had 13,729 Acrivon Therapeutics, Inc. shares withheld for tax (Form 4)

Traded May 21, 2026 · Filed May 26, 2026

On May 21, 2026, Masson Kristina (Director, EVP - Business Operations) had 13,729 Acrivon Therapeutics, Inc. shares withheld for tax at US$1.79 for US$24,575, leaving 2,245,317 shares. Filed May 26, 2026 (Form 4).

Withheld for tax
13,729 shares
Price
US$1.79
Value
US$24,575
Holding after
2,245,317 shares
Trading plan
No
Role
Director, EVP - Business Operations

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
May 21, 2026Common StockShares withheld for tax13,729US$1.792,245,317Direct

Source

View original at SEC

Related